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Development of bacteremia in the presence of a central line is
a monitored nursing sensitive indicator. It also affects the
nurses’ ability to care for the BMT patient since the central line
is usually removed when this diagnosis is made. A random-
ized controlled study evaluating the efﬁcacy of short term
versus long term cryotherapy during Melphalan administra-
tion for the prevention of severe mucositis was recently
completed at our institution. One of the data pieces collected
during this nursing intervention study was the development
of bacteremia. Greater than 20% of the study patients devel-
oped bacteremia. Retrospective review showed that prior to
cryotherapy implementation the rate was nearly 0%, however,
it was noted that Ciproﬂoxacin prophylaxis was being used
during that period.
Methods, Intervention, & Analysis: Study data as well as a
literature review were presented during a BMT program
quality meeting where multidisciplinary team members,
including Epidemiology, were present for discussion. Based
on the organisms identiﬁed (many Gram negative organisms
likely translocated via the damaged GI mucosa), the day of
transplant onwhich theywere identiﬁed (Day +6 to +10), and
the concern for increased incidence of C. difﬁcile, a plan was
agreed upon. Levoﬂoxacin is now being administered
beginning on Day +4 until Day +9 to patients with Multiple
Myeloma who are receiving an autologous BMT with
Melphalan as the preparative regimen.
Findings & Interpretation: Analysis of 2 months of data (24
patients) shows the bloodstream infection rate is down to
<5% and the rate of C. difﬁcile has not changed. Although this
is a small sample of data, more than 6 months of data will be
available prior to presentation at the Tandem meeting.
Discussion & Implications: This practice change was
implemented in a controlled single population. Based on the
impact already noted, our program is considering imple-
menting this same practice change to other populations who
also receive Melphalan as part of their preparative regimen.
This practice change has positively impacted patients by
allowing them to keep their central line throughout their
transplant course and eliminating the need for them to be
discharged on antibiotic therapy. Continued data monitoring
related to this change is occurring.581
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Studies demonstrate that strength training and cardiovascular
exercise enhance the physical and psychological health of
patients undergoing allogeneic BMT (Wiskemann, 2011;Baumann, 2011; Jarden, 2012). Accreditation quality standards
(ACOS, 2012; FACT, 2014) require patients to receive pre-
transplant evaluation, training and post-transplant follow-up.
Methods, Intervention, & Analysis: With expansion of our
BMT program to include allogeneic transplantation, we
formulated a focus group, to develop the infrastructure for a
BMT-speciﬁc physical therapy program. An interdisciplinary
team consisting of physical therapists, a physiatrist and BMT
clinical team met to explore best practice, deﬁne medical
eligibility, create educational materials, secure resources, and
develop policy and procedure. Dedicated physical therapists
implemented the protocols and measured the effectiveness
of physical ﬁtness using standardized tools throughout all
phases of BMT. A specially equipped room within the BMT
Unit is utilized during scheduled clinic visits and inpatient
stays. Physical activity regimens include strength training
two days per week and endurance training three days per
week. All patients receive pre-transplant counseling, exer-
cise sessions during transplant clinic visits, and are re-eval-
uated 12 weeks post-BMT.
Findings & Interpretation: The exercise program was well
received by patients, caregivers and staff. Preliminary ﬁnd-
ings support the positive impact of exercise. Maps delin-
eating walking distances motivated patients to achieve their
goals. BMT nurses recognized and encouraged exercise dur-
ing the patient’s BMT journey.
Discussion & Implications: Clinical programs can efﬁ-
ciently and effectively develop a structured exercise pro-
gram for patients undergoing allogeneic BMT. Obtaining
dedicated resources in these economically challenging
times and educating patients, caregivers, and BMT staff
remain an important focus of our program. We hope that
our model and process will serve as an exemplar to other
BMT programs.583
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
A Stem Cell Transplant unit presents unique challenges for fall
initiatives. Relatively healthy patients admitted to a private
room, and effectively isolated behind closed doors, are chal-
lenged with progressive weakness and fatigue following their
preparative regimen. As they become a greater risk for falls,
patients also develop pancytopenia, increasing their risk of
injury. The purpose of this study was to develop an inter-
professional, multimodal protocol to address rising fall rates
on the Stem Cell Transplant unit. Literature review revealed
the utilization of multiple strategies concurrently resulted in
greater improvement in fall rates.
Methods, Intervention, & Analysis: The culture of “patients
fall” perception was challenged.
A unit speciﬁc fall risk patient teaching tool was
developed.
A Staff Safety Pledge was signed by all staff members.
Daily rounding on patients by Charge Nurse and Manager
to validate bed alarm usage.
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meetings to review circumstances surrounding falls.
Medications review to determine those that most greatly
increase risk of falls. Patients not assessed as high fall risk
were placed on bed alarms for two hours after receiving
these meds.
All staff members received education on Crucial Conver-
sations and how to address patients’ refusal of bed alarm
usage.
Continued refusal of the bed alarm was escalated to
nursing leadership.
Collaboration with Physical Therapyethe use of a
communication board to report activity and required assis-
tance by staff.
Findings & Interpretation: 2012 total falls were 19, fall rate
3.02/ 1000 patient days.
2013 total falls were 27, fall rate 4.45/ 1000 patient days.
2014 falls through 3rd quarter is 10, fall rate 2.08/ 1000
patient days.
Discussion & Implications: Consistent implementation of
any strategy is the best way to ensure sustained results.
Nurse leader rounding to validate use of the bed alarm and
consistent messaging to staff and patients is necessary to
keep protocols high priority.
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Autologous stem cell transplant (ASCT) and various novel
drug combination strategies are designed to improve
outcome. Relapse within 12 months of stem cell transplant
predicts poor outcome for patients with (MM). Historically,
extramedullary plasmacytomas are not included in staging or
as a prognostic feature for patients undergoing transplants for
multiple myeloma.
Methods, Intervention, & Analysis: We evaluated charac-
teristics of plasmacytomas (PCM) in patients undergoing
ASCT transplant for diagnosis of MM. We retrospectively
analyzed 251 consecutive (M137:F107) ASCTs for MM be-
tween December 2011 and June 2014, after new triple com-
bination agents were introduced in the therapy of (MM).
Median agewas 57 years (38-76) and length of follow-upwas
538 days (120 - 1042 days). Bone marrow cytogenetics was
available in 230 (94.3%) patients. Various pretransplantcharacteristics including age, cytogenetics, and plasma cell
percentage were evaluated for impact on overall survival and
disease progression.
A total of 159 (65%) patients had either extraosseous or
extramedullary plasmacytomas at presentation and 85 (35%)
patients had no lytic lesions or any plamacytomas. 52 (21.3%)
patients had extramedullary PCM without any lytic lesions.
Plasma cells > 20% was seen in 38.2% (n¼20) in PCM
compared to 62% (n¼152) in whole group. Prior MGUS
(n¼26) or smoldering myeloma (n¼7) was seen in 14% (33/
244) patients but only 7.6% (4/52) in PCM group. Prior soli-
tary Plasmacytomas were seen in 21%( 11/52) PCM patients.
Trisomy 11 or t (11:14) was seen in 3% (n¼8) in PCM
compared to 12% (n¼6) in all pts. Hyperdiploidy was seen in
4% (2/52) compared to 9% (22/244) patients.
Findings & Interpretation: The median survival was 623
days (20 days -1897 days) for PCM patients compared to 522
days (89 days -1897 days) for all patients. PCM pts developed
recurrent PCM after autologous transplant in 33% (17/52)
cases. One third of patients with recurrent PCM (6/17) died of
(PCM) progression.
Discussion & Implications: In conclusion, patients pre-
senting as PCM have more aggressive clinical presentation.
Pre and post transplant strategies need to be better deﬁned
to improve outcome of patients with PCM recurrences post
transplant.586
A Team Approach to Decreasing Clabsi Rates in a BMTU
Rebecca A. Norton 1, Jamie Dees 2. 1 Bone Marrow Transplant
Inpatient Unit, UF Health Shands Hospital, Gainesville, FL;
2 Bone Marrow Transplant In-patient, UF Health Shands
Hospital, Gainesville, FL
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Prolonged neutropenia and mucosal barrier breakdown are
major treatment related toxicities contributing to central line
associated blood stream infections (CLABSIs) in bone marrow
transplant recipients. CLABSIs are preventable, costly, and
potentially deadly. Bone Marrow Transplant nurses have the
ability to reduce the number of CLABSIs through a variety of
techniques and practices.
Methods, Intervention, & Analysis: An evaluation of cur-
rent practice and areas for improvement were identiﬁed
which led to the development of a comprehensive unit based
safety program (CUSP) team. A “Back to Basics Campaign”
was initiated by the team that included proper hand hygiene,
aseptic techniques when accessing central lines, environ-
mental practices, and blood culture procedure techniques.
Additionally, there were speciﬁc nurse and patient educa-
tion, environmental practices (i.e., high-touch surface infec-
tion control, decreasing clutter in recipient rooms, ultra
violet light decontamination cleaning, isolation practice
changes), and CLABSI drill downs by the clinical nurse leader
and team. CLABSI rates were measured before and after
implementation of education and clinical practice changes.
The overall goals were to improve patient outcomes and
reduce CLABSI rates below national benchmark. Compliance
audits were performed weekly by nursing leadership to
validate nurse and patient practices.
Findings & Interpretation: CLABSI rates prior to imple-
mentation were 9.938 and three months after the in-
terventions were 2.42. Mucosal barrier infections were
unpreventable and included in the data.
